In VTE at high risk for recurrence, reduced- vs. full-dose DOACs did not differ for symptomatic recurrence but reduced bleeding at 37 mo.
Sign Up to like & getrecommendations! Published in 2025 at "Annals of internal medicine"
DOI: 10.7326/annals-25-01856-jc
Abstract: CLINICAL IMPACT RATINGS GIM/FP/GP: [Formula: see text] Hematology: [Formula: see text]. read more here.
Keywords: risk recurrence; recurrence reduced; high risk; vte high ... See more keywords